Jump to content

20250179151. Spike (University of Virginia Patent Foundation)

From WikiPatents

SPIKE FURIN CLEAVAGE IS A SARS-COV-2 TARGETING STRATEGY TO BREAK THE CHAIN OF INFECTION CYCLE

Abstract: provided are methods for treating viral infections in subject in need thereof. in some embodiments, the method include administering to the subject a composition that has an effective amount of an agent that selectively interferes with host protease function to inhibit fusion-ready viral fragment generation, optionally s2 in case of sars-cov2 or gp160 or gp120 in case of hiv, and/or to destabilize a full-length viral fusion protein, optionally sars-cov-2 spike. also provided are compositions that include an effective amount of an agent that selectively interferes with host protease function to inhibit fusion-ready viral fragment generation, optionally s2 in case of sars-cov2 or gp160 or gp120 in case of hiv, and/or to destabilize a full-length viral fusion protein, optionally sars-cov-2 spike, which compositions can optionally be employed in the disclosed methods.

Inventor(s): Jogender Tushir-Singh

CPC Classification: C07K16/1003 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250179151


Cookies help us deliver our services. By using our services, you agree to our use of cookies.